1887

Abstract

SUMMARY

Rabbits and rhesus monkeys were injected with 3 × 10 units of human gamma interferon (IFN) prepared in human leukocyte suspensions. Circulating IFN was detected up to 4 h after intravenous administration. Intramuscular injection maintained a relatively stable serum IFN level of about 50 units/ml for 7 to 9 h. The results in both species were similar. Little or no circulating IFN was detected after subcutaneous injection of 3 × 10 units, but 1.5 × 10 units maintained about 50 units per ml of serum for 30 h. Pharmacokinetically, human gamma IFN resembled human alpha interferons rather than human beta IFN.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-64-8-1823
1983-08-01
2022-10-04
Loading full text...

Full text loading...

/deliver/fulltext/jgv/64/8/JV0640081823.html?itemId=/content/journal/jgv/10.1099/0022-1317-64-8-1823&mimeType=html&fmt=ahah

References

  1. Cantell K., Pyhälä L. 1976; Pharmacokinetics of human leukocyte interferon. Journal of Infectious Diseases 133:6–12
    [Google Scholar]
  2. Cantell K., Pyhälä L., Strander H. 1974; Circulating human interferon after intramuscular injection into animals and man. Journal of General Virology 22:453–455
    [Google Scholar]
  3. Cantell K., Hirvonen S., Kauppinen H.L., Myllyla G. 1981; Production of interferon in human leukocytes from normal donors with the use of Sendai virus. Methods in Enzymology 78:29–38
    [Google Scholar]
  4. Edy V. G., Billiau A., De Somer P. 1978; Non-appearance of injected fibroblast interferon in circulation. Lancet 1:451–452
    [Google Scholar]
  5. Gutterman J. U., Fine S., Quesada J., Hornings S. L., Levine J. F., Alexanian R., Bernhardt L., Kramer M., Spiegel H., Colburn W., Trown P., Merigan T. C., Dziewanowski Z. 1982a; Recombinant leukocyte A interferon: pharmacokinetics, single-dose tolerance, and biologic effects in cancer patients. Annals of Internal Medicine 96:549–556
    [Google Scholar]
  6. Gutterman J. U., Rios A., Quesada J. R., Rosenblum M. 1982b; Partially pure human immune (gamma) interferon: a phase I pharmacological study in cancer patients. Abstract of The Third International Congress for Interferon Research Miami, Florida:
    [Google Scholar]
  7. Mogensen K. E., Pyhälä L., Cantell K. 1975; Raising antibodies to human leucocyte interferon. Acta pathologica et microbiologica scandinavica 83B:443–450
    [Google Scholar]
  8. Priestman T. J. 1980; Initial evaluation of human lymphoblastoid interferon in patients with advanced malignant disease. Lancet ii:113–118
    [Google Scholar]
  9. Quesada J. R., Gutterman J. U., Hersch E. M. 1982; Clinical and immunological study of beta interferon by intramuscular route in patients with metastatic breast cancer. Journal of Interferon Research 2:593–599
    [Google Scholar]
  10. Ronnblom L., Funa K., Ersson B., Alm G. V. 1982; Lectins as inducers of interferon-y production in human lymphocytes: lentil lectin is highly efficient. Scandinavian Journal of Immunology 16:327–331
    [Google Scholar]
  11. Stewart W. E. H., Wiranows-kaStewart M. 1980; Characterization of human interferon types and subtypes: physicochemical and pharmacological distinctions between interferons type I and II. In Interferon: Properties and Clinical Uses pp 111–117 Edited by Khan A., Hill N. O., Dorn G. L. Dallas: Leland Fikes Foundation Press;
    [Google Scholar]
  12. Weck P. K., Shalaby M. R., Apperson S., Gray P. W., Goeddel D. V. 1982; Comparative biological properties of human alpha, beta and gamma IFNs derived from bacteria. Abstract of The Third International Congress for Interferon Research Miami, Florida:
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-64-8-1823
Loading
/content/journal/jgv/10.1099/0022-1317-64-8-1823
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error